Dietetic effects of oral intervention with mare's milk on the Severity Scoring of Atopic Dermatitis, on faecal microbiota and on immunological parameters in patients with atopic dermatitis

International Journal of Food Sciences and Nutrition

Volumn 60, Issue SUPPL. 7, 2009, Pages 41-52

  Foekel, Corina ^a   Schubert, Rainer ^a   Kaatz, Martin ^b   Schmidt, Ivonne ^b   Bauer, Andrea ^b   Hipler, Uta Christina ^b   Vogelsang, Heinz ^a   Rabe, Katja ^a   Jahreis, Gerhard ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Clinic of Dermatology and Allergology   (Germany)

Author keywords

Atopic dermatitis; Bifidobacteria; Endogenous eczema; Mare's milk; Severity Scoring of Atopic Dermatitis

Indexed keywords

C REACTIVE PROTEIN;

ANIMAL; ARTICLE; ATOPIC DERMATITIS; BIFIDOBACTERIUM; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; DIET THERAPY; DOUBLE BLIND PROCEDURE; ENTEROCOCCUS; FECES; FEMALE; GRANULOCYTE; HORSE; HOSPITALIZATION; HUMAN; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; ISOLATION AND PURIFICATION; LACTOBACILLUS; MALE; MICROBIOLOGY; MILK; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TIME;

ANIMALS; BIFIDOBACTERIUM; C-REACTIVE PROTEIN; CROSS-OVER STUDIES; DERMATITIS, ATOPIC; DIET; DOUBLE-BLIND METHOD; ENTEROCOCCUS; FECES; FEMALE; GRANULOCYTES; HORSES; HUMANS; LACTOBACILLUS; MALE; MILK; MONITORING, IMMUNOLOGIC; PILOT PROJECTS; PRURITUS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

BACTERIA (MICROORGANISMS);

EID: 77951447243     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.1080/09637480802249082     Document Type: Article

References (51)

1. Andersson Y, Lindquist S, Lagerqvist C, Hernell O. 2000. Lactoferrin is responsible for the fungistatic effect of human milk. Early Hum Dev 59:95-105.q
2. Angelova-Fischer I, Hipler UC, Bauer A, Fluhr JW, Tsankov N, Fischer TW, Elsner P. 2006. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis*from laboratory parameters to clinical scores. Br J Dermatol 154:1112-1117.q
3. Bahmer FA, Schaefer J. 1992. Treatment of atopic dermatitis with borage seed oil (Glandol)*a time series analytic study. Kinderaerztl Praxis 60:199-202.q
4. Breuer K, Kapp A, Werfel T. 2001. Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age. Allergy 56:780-784.q
5. Buehlbaecker A. 1996. Zur Verwendbarkeit von Stutenmilch, Kumyss und Eselmilch als Dietetika und Heilmittel unter besonderer Beruecksichtigung der Beduerfnisse des Saeuglings und des Fruehgeborenen. Thesis, Privat-Univ. Witten, Herdecke, Verlag Haensel-Hohenhausen, Frankfurt am Main.q
6. Caccavo D, Pellegrino NM, Altamura M, Rigon A, Amati L, Amoroso A, Jirillo E. 2002. Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application. J Endotoxin Res 8:403-417.q
7. Consensus Report of the European Task Force on Atopic Dermatitis. 1993. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 186:23-31.q
8. Cruikshank W, Kornfeld H, Certer D. 2000. Interleukin-16. J Leukoc Biol 67:757-766.q
9. Czech W, Krutmann J, Schoepf E, Kapp A. 1992. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 126:351-355.q
10. Ellinger S, Linscheid KP, Jahnecke S, Goerlich R, Enbergs H. 2002. The effect of mare's milk consumption on functional elements of phagocytosis of human neutrophil granulocytes from healthy volunteers. Food Agric Immunol 14:191-200.q
11. Frezzolini A, Paradisi M, Zaffiro A, Provini A, Cadoni S, Ruffelli M, De Pità O. 2002. Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity. Allergy 57:815-820.q
12. Furue M, Koga T, Yamashita N. 1999. Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis. Br J Dermatol 140:67-72.q
13. Gall H, Kalveram CM, Sick H, Sterry W. 1996. Allergy to the heat-labile proteins a-lactalbumin and b-lactoglobulin in mare's milk. J Allergy Clin Immunol 97:1304-1307.q (Pubitemid 126749661)
14. Grover M, Giouzeppos O, Schnagl RD, May JT. 1997. Effect of human milk prostaglandins and lactoferrin on respiratory syncytial virus and rotavirus. Acta Paediatr 86:315-316.q
15. Harmsen HJM, Elfferich P, Schut F, Welling GW. 1999. A 16 S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 11:3-12.q
16. Hatzipanagiotou A, Rieland E, Enbergs H. 1998. The activity of lysozyme in the milk of sucking mares during the lactation period. Deut Tierarztl Wochenschr 105:148-152.q
17. He F, Morita H, Ouwehand AC, Hosoda M, Hiramatsu M, Kurisaki J, Isolauri E, Benno Y, Salminen S. 2002. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol Immunol 46:781-785.q
18. Henz BM, Jablonska S, van de Kerkhof PC, Stingl G, Blaszczyk M, Vandervalk PG, Veenhuizen R, Muggli R, Raederstorff D. 1999. Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol 140:685-688.q
19. Ibrahim HR, Aoki T. 2003. New promises of lysozyme as immune modulator and antimicrobial agent for nutraceuticals. Foods Food Ingredients J Jpn 208:361-374.q
20. Kaegi MK, Joller-Jemelka H,Wuethrich B. 1992. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 185:88-92.q
21. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Komine M, Asahina A, Tamaki K. 2002. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 127:270-273.q
22. Kalliomaeki M, Isolauri E. 2003. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 3:15-20.q
23. Kaminishi K, Soma Y, Kawa Y, Mizoguchi M. 2002. Flow cytometric analysis of IL-4, IL-13 and IFNgamma expression in peripheral blood mononuclear cells and detection of circulating IL13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease. J Dermatol Sci 29:19-25.q
24. Kim WS, Ohashi M, Tanaka T, Kumura H, Kim GY, Kwon IK, Goh JS, Shimazaki K. 2004. Growthpromoting effects of lactoferrin on L. acidophilus and Bifidobacterium spp. Biol Metals 17:279-283.q
25. Klein A, Friedrich U, Vogelsang H, Jahreis G. 2008. Lactobacillus acidophilus 74-82 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur J Clin Nutr 62:584-593.q
26. Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MHF, Welling GW. 1995. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNAtargeted probes and its application in fecal samples. Appl Eviron Microb 61:3069-3075.q
27. Laouini D, Alenius H, Bryce P, Oettghen H, Tsitsikov E, Geha RS. 2003. OL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 112:1058-1066.q
28. Laske N, Niggemann B. 2004. Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol 15:86-88.q
29. Lee-Huang S, Huang PL, Sun Y, Huang PL, Kung HF, Blithe DL, Chen HC. 1999. Lysozyme and RNase as anti-HIV components in b-core preparations of human chorionic gonadotropin. Biochemistry 96:2678-2681.q
30. Leitch EC, Willox MD. 1998. Synergic antistaphylococcal properties of lactoferrin and lysozyme. J Med Microbiol 47:837-842.q
31. Maneva A, Taleva B, Maneva L. 2003. Lactoferrin-protector against oxidative stress and regulator of glycolysis in human erythrocytes. Z. Naturforsch 58:256-262.q
32. Marchetti M, Longhi C, Conte MP, Pisani S, Valenti P, Seganti L. 1996. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res 29:221-231.q
33. Murakami F, Sasaki T, Sugahara T. 1997. Lysozyme stimulates immunoglobulin production by humanhuman hybridoma and human peripheral blood lymphocytes. Cytotechnology 24:177-182.q (Pubitemid 27222180)
34. Ogundele MO. 1998. A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation. Mediat Inflamm 7:363-365.q
35. Orla MC. 2001. Antiinflammatory activities of lactoferrin. J Am Coll Nutr 20:S389-S395.q
36. Orsi N. 2004. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 17: 189-196.q
37. Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. 2001. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 108:144-145.q (Pubitemid 32662250)
38. Pahud JJ, Mach JP. 1972. Equine secretory IgA and secretory component. Int Arch Allergy 42:175-186.q
39. Pucci N, Lombardi E, Novembre E, Farina S, Bernardini R, Rossi E, Favilli T, Vierucci A. 2000. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity. J Allergy Clin Immunol 105:353-357.q (Pubitemid 30109051)
40. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A. 2003. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111:389-395.q (Pubitemid 36228562)
41. Sandomirsky BP, Galchenko SE, Galchenko KS. 2003. Antioxidative properties of lactoferrin from bovine colostrum before and after its lyophilization. Cryo Lett 24:275-280.q
42. Sava G, Ceschia V, Pacor S. 1989. Mechanism of the antineoplastic action of lysozyme: evidence for host mediated effects. Anticancer Res 9:1175-1180.q (Pubitemid 19266376)
43. Sistek D, Kelly R, Wickens K, Stanley T, Fitzharris P, Crane J. 2006. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin Exp Allergy 36:629-633.q
44. Solaroli G, Pagliarini E, Peri C. 1993. Composition and nutritional quality of mare's milk. Ital J Food Sci 1:3-10.q
45. Steward JCM, Morse PF, Moss M, Horrobin DF, Burton JL, Douglas WS, Gould DJ, Grattan CEH, Hindson TC, Anderson J, Jansén CT, Kennedy CTC, Lindskov R, Strong AMM, Wright S. 1991. Treatment of severe and moderately severe atopic dermatitis with evening primrose oil (Epogam): a multicentre study. J Nutr Med 2:9-15.q
46. Tischendorf FW, Brattig NW, Lintzel M, Buettner DW, Burchard GD, Bork K, Mueller M. 2000. Eosinophil granule proteins in serum and urine of patients with helminth infections and atopic dermatitis. Trop Med Int Health 5:898-905.q (Pubitemid 32115929)
47. Tobgi RS, Samaranayake LP, MacFarlane TW. 1988. In vitro susceptibility of Candida species to lysozyme. Oral Microbiol Immunol 3:35-39.q
48. Togawa JI, Nagase H, Tanaka K, Inamori M, Umezawa T, Nakajima A, Naito M, Sato S, Saito T, Sekihara H. 2002. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am J Physiol Gastrointest Liver Physiol 283:187-195.q
49. Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. 2005. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60:494-500.q
50. Wallace AB. 1951. The exposure treatment of burns. Lancet 1:501-504.q
51. Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, Kumemura M. 2003. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 111:587-591.q (Pubitemid 36337881)